Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.
Primrose Bio has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in July 2026.
Primrose Bio's investors include National Science Foundation, NCATS.
Primrose Bio is headquartered in San Diego, United States.
Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.
Primrose Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Primrose Bio — Funding & Investors." VCBacked, July 15, 2026, https://www.vcbacked.co/company/primrose-bio. Accessed September 14, 2026.
VCBacked. (2026). Primrose Bio — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/primrose-bio
{{cite web |title=Primrose Bio — Funding & Investors |url=https://www.vcbacked.co/company/primrose-bio |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated